期刊文献+

干细胞标志物Nanog、Oct-4、SOX-2表达与结肠癌术后复发转移关系 被引量:5

Correlation of expression of Nanog, Oct-4 and SOX-2 with tumor metastasis in colonic cancer
下载PDF
导出
摘要 目的:探讨结肠癌患者肿瘤组织中Nanog、Oct-4、SOX-2表达情况及其对远处转移的预测作用.方法:采用免疫组织化学方法检测经手术切除的80例结肠癌术后标本中Nanog、Oct-4、SOX-2表达情况,并且对三种指标的表达同肿瘤分化程度、分期和术后复发转移关系进行分析.结果:80例患者有35例出现复发转移,SOX-2、Oct-4、Nanog在转移组患者中表达率分别为48.57%(17/35)、51.43%(18/35)、60%(21/35),在非转移组中表达率分别为17.78%(8/45)、13.33%(6/45)、26.67%(12/45)差异有统计学意义.原发灶分化程度仅同Nanog表达差异有统计学意义(P=0.001).但是三指标表达同T分期和N分期没有明显联系.三者均为表达阳性其转移率明显高于均为阴性转移率,生存分析显示不同表达状态其远处转移出现时间差异有统计学意义(P=0.0001).结论:组织中Nanog、Oct-4、SOX-2表达同结肠癌术后复发转移发生相关,联合检测有助于评估肿瘤转移情况. AIM: To investigate the expression of Nanog, Oct4 and SOX-2 in colonic carcinoma and to analyze their relationship with tumor metastasis.METHODS: Immunohistochemistry was used to evaluate the expression of Nanog, Oct-4 and SOX-2 in 80 colonic cancer surgical specimens. The correlation of Nanog, Oct-4 and SOX-2 expression with tumor histological differentiation,T stage, N stage and metastasis was analyzed.RESULTS: Thirty-five patients had metastasis. The positive rates of SOX-2, Oct-4 and Nanog expression were significantly higher in the me- tastasis group than in the non-metastasis group (48.57% vs 17.78%, 51.43% vs 13.33%, 60% vs 26.67%, all P 〈 0.05). Nanog expression was significantly correlated with differentiation (P = 0.001), but expression of Nanog, Oct-4 and SOX-2 was not associated with T stage or N stage. Metastatic rate was higher in patients with positive expression of the three markers than in those with negative expression. Survival analysis showed that the time to develop metastasis was significant different among patients with differential expression of the three markers (P = 0.0001).CONCLUSION: The expression of Nanog, Oct-4 and SOX-2 in tumor tissue can predict the post-operative metastasis of colonic cancer. Nanog, Oct-4 and SOX-2 are promising predictors for metastasis of colonic cancer.
出处 《世界华人消化杂志》 CAS 北大核心 2011年第25期2644-2648,共5页 World Chinese Journal of Digestology
基金 河南省卫生厅资助项目 No.WKJ2007-2-026 No.201102171~~
关键词 结肠癌 NANOG OCT-4 SOX-2 转移 Colonic cancer Nanog Oct-4 SOX-2 Metastasis
  • 相关文献

参考文献31

二级参考文献189

共引文献73

同被引文献42

  • 1卢浩,叶建新,赵桂斌.大肠癌肿瘤组织中干细胞关键转录因子Oct4的表达及意义[J].黑龙江医学,2009,33(1):13-15. 被引量:3
  • 2杨玲,李连弟,陈育德,D.M.Parkin.中国2000年及2005年恶性肿瘤发病死亡的估计与预测[J].中国卫生统计,2005,22(4):218-221. 被引量:336
  • 3Zhao P, Dai M, Chen W, Li N. Cancer trends in China. Jpn J Clin Oncol 2010; 40: 281-285.
  • 4Zhang XY, Varthi M, Sykes SM, Phillips C, Warzecha C, Zhu W, Wyce A, Thorne AW, Berger SL, McMahon SB. The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression. Mol Cell 2008; 29: 102-111.
  • 5Yang DD, Cui BB, Sun LY, Zheng HQ, Huang Q, Tong JX, Zhang QF. The co-expression of USP22 and BMI-1 may promote cancer progression and predict therapy failure in gastric carcinoma. Cell Biochem Biophys 2011; 61: 703-710.
  • 6Zhang Y, Yao L, Zhang X, Ji H, Wang L, Sun S, Pang D. Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer. J Cancer Res Clin Oncol 2011; 137: 1245-1253.
  • 7Glinsky GV. Death-from-cancer signatures and stem cell contribution to metastatic cancer. Cell Cycle 2005; 4: 1171-1175.
  • 8Glinsky GV. Genomic models of metastatic cancer: functional analysis of death-from-cancer signature genes reveals aneuploid, anoikis-resistant, metastasis-enabling phenotype with altered cell cycle control and activated Polycomb Group (PcG) protein chromatin silencing pathway. Cell Cycle 2006; 5: 1208-1216.
  • 9Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, Maruyama M, Maeda M, Yamanaka S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003; 113: 631-642.
  • 10Gu G, Yuan J, Wills M, Kasper S. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res 2007; 67: 4807-4815.

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部